Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Journal of Neuro-Oncology|June 5, 2010
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapyKatherine B Peters, Thomas E Coyle, James J Vredenburgh, et al.Expert Opinion on Pharmacotherapy|August 3, 2011
Everolimus tablets for patients with subependymal giant cell astrocytomaScott G Turner, Katherine B Peters, James J Vredenburgh, et al.Current Medical Research and Opinion|March 16, 2007
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomitingEyal Meiri, Haresh Jhangiani, James J Vredenburgh, et al.Sarcoma|July 21, 2011
Primary meningeal rhabdomyosarcomaManisha Palta, Richard F Riedel, James J Vredenburgh, et al.Journal of Neuro-Oncology|May 6, 2009
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patientsStephanie L Perry, Cindy Bohlin, David A Reardon, et al.Cancer|July 13, 2002
Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescuePehr A Lind, Lawrence B Marks, Timothy A Jamieson, et al.Journal of Neuro-Oncology|December 19, 2009
Bevacizumab fails to treat temporal paraganglioma: discussion and case illustrationHamidreza Aliabadi, James J Vredenburgh, Richard G Everson, et al.Neuro-Oncology|May 25, 2007
Activity of VNP40101M (Cloretazine) in the treatment of CNS tumor xenografts in athymic miceMichael A Badruddoja, Stephen T Keir, Ivan King, et al.Cancer|July 28, 2011
Bevacizumab and daily temozolomide for recurrent glioblastomaAnnick Desjardins, David A Reardon, April Coan, et al.Neuro-Oncology|July 10, 2010
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label studyW K Alfred Yung, James J Vredenburgh, Timothy F Cloughesy, et al.Pageof 11